Skip to main content
CNSP logo

CNSP

CNS Pharmaceuticals, Inc.
$5.07 +0.39 (+8.33%) At close · Jul 2
Market Cap
$7.41M
Shares
1,461,449

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 11
Total Value: $347,970
Total Shares: 145,596

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 11 13F filers · Δ vs Dec 31, 2025
Top Holder
41.9%
Jun 2025 → Mar 2026 · range 39.3% – 100.0%
+2.6 pts
Top 5
99.5%
Jun 2025 → Mar 2026 · range 99.5% – 100.0%
−0.5 pts
Top 10
100.0%
Jun 2025 → Mar 2026 · range 100.0% – 100.0%
−0.0 pts
HHI
3,087
Jun 2025 → Mar 2026 · range 3,087 – 10,000
Highly concentrated−91

Quarterly Activity

vs Dec 31, 2025
New
4
Increased
1
Decreased
2
Sold Out
2
Unchanged
4
Holder count: +2
Institutional value: -69.7%
Shares held: -33.5%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 11 of 11
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1729427 CUSIP 18978H508 Visit website Investor relations